首页> 外文期刊>Vojnosanitetski Pregled >Survival outcomes in surgically treated patients with advanced laryngeal cancer in Serbia
【24h】

Survival outcomes in surgically treated patients with advanced laryngeal cancer in Serbia

机译:塞尔维亚患有外科治疗喉癌患者的存活结果

获取原文
           

摘要

Background/Aim. Laryngeal carcinomas make 1%?3% of all head and neck malignancies.Treatment outcome and survival rates depend greatly on established stage of the disease. The purpose of this study was to examine the survival of the patients with advanced laryngeal carcinoma depending on gender, age, common risk factors (tobacco and alcohol use), primary tumor localization, histopathological tumor grade, clinical TNM (tumor, node and metastasis) stage and surgical treatment of the disease. Methods. Retrospective study included 252 patients treated surgically for advanced squamocellular carcinoma of the larynx in a threeyear period with five-year follow-up. Patients included in the study were treated primary with surgery, with postoperative radiotherapy and chemotherapy depending on the stage of the disease, intraoperative findings and tumor resection borders. Overall survival and disease-specific five-year survival of patients was calculated for demographical and clinical characteristics of the patients. Results. Overall 5-year survival of patients with operable advanced laryngeal cancer included in the study was 86.14% and disease-specific survival 86.51%. Lower overall and the disease-specific survival was associated with age, higher histological tumor grade and more extensive neck dissections. Conclusion. Primary total laryngectomy results in higher survival outcomes in cases of transglottic T3 and T4a laryngeal tumors. Patients should be informed of the likely increased mortality risks tied to the choice of surgical resection and treatment modality before their decision.
机译:背景/目标。喉癌癌均为1%?3%的所有头部和颈部恶性肿瘤。治疗结果和生存率大大依赖于疾病的既定阶段。本研究的目的是根据性别,年龄,常见风险因素(烟草和酒精),原发性肿瘤定位,组织病理肿瘤等级,临床TNM(肿瘤,节点和转移)生存患者的生存。阶段和手术治疗疾病。方法。回顾性研究包括252名患者,用于喉部前期喉咙治疗的喉头癌,在三年后续期间进行了五年的随访。该研究中包含的患者均用手术治疗,术后放疗和化疗取决于疾病的阶段,术中发现和肿瘤切除边界。针对患者的人口统计和临床特征计算了患者的整体存活和疾病特异性的五年存活。结果。该研究中包含的可操作晚期喉癌患者的总体5年生存率为86.14%,疾病特异性生存86.51%。总体而言和疾病特异性存活率与年龄较高,组织学肿瘤等级和更广泛的颈部剖析有关。结论。初级总喉切除术导致转膜T3和T4A喉肿瘤的病例中的生存结果较高。应告知患者可能会提高死亡率,并在决定前选择手术切除和治疗方式。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号